ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED

OrbusNeich Medical Group Holdings Limited

Equities

6929

KYG6773B1005

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
3.83 ^HKD	+4.08%		+6.09%	-45.67%

Mar. 07	OrbusNeich Medical Group’s Profit Up 144% in 2023	MT
Mar. 07	OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024	CI

OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024

March 07, 2024 at 05:26 am EST

OrbusNeich Medical Group Holdings Limited proposed final dividend of HKD 0.1 per share for the Year Ended December 31, 2023, payable on 28 June 2024. Ex-dividend date is on 11 June 2024 with Record date on 17 June 2024. Date of shareholders' approval on 06 June 2024.

Latest news about OrbusNeich Medical Group Holdings Limited

OrbusNeich Medical Group’s Profit Up 144% in 2023	Mar. 07	MT
OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024	Mar. 07	CI
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
OrbusNeich Medical Seeks M&A Opportunities	Mar. 07	CI
OrbusNeich Medical Group Holdings Limited acquired SJ Medicare Co. Ltd.	Mar. 06	CI
OrbusNeich Expects More Than Doubling of 2023 Profit	Jan. 30	MT
Certain Ordinary Shares of OrbusNeich Medical Group Holdings Limited are subject to a Lock-Up Agreement Ending on 22-DEC-2023.	Dec. 21	CI
OrbusNeich Medical Subsidiary Buys 84% Stake in Indonesian Medical Device Maker	Nov. 26	MT
OrbusNeich Medical to Acquire Eucatech for 2.4 Million Euros	Nov. 23	MT
OrbusNeich Medical Group Holdings Limited acquired Eucatech AG for ?2.4 million.	Nov. 22	CI
OrbusNeich Medical Extends Term of Exclusive US Distributor of Products to 2027	23-09-27	MT
Orbusneich Medical Group Holdings Limited and Cardiovascular Systems, Inc. Enters into an Amendment to Distribution Agreement	23-09-27	CI
OrbusNeich Medical Group Holdings Limited(SEHK:6929) added to S&P Global BMI Index	23-09-18	CI
OrbusNeich Medical Group Holdings Limited Announces Retirement of Ching Chung John Chow from the Group of All Executive Roles and Has Been Re-Designated as Non-Executive Director with effect from September 7, 2023	23-09-06	CI
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
OrbusNeich to Log 200% Boost in H1 Profit	23-07-31	MT
OrbusNeich Medical Group Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023	23-07-31	CI
Certain Ordinary Shares of OrbusNeich Medical Group Holdings Limited are subject to a Lock-Up Agreement Ending on 22-JUN-2023.	23-06-21	CI
OrbusNeich Medical Group Holdings Limited Appoints Ting San Peter Lionel LEUNG as Non-Executive Director	23-05-23	CI
OrbusNeich Medical to Set Up R&D, Production Base for 300 Million Yuan	23-03-29	MT
OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
China's Rising COVID Infections Breaks Hong Kong Stocks' Two-Day Gaining Spell; Fifth SPAC Untraded, Two Firms Gain in Debut	22-12-23	MT
OrbusNeich Debuts Flat in Hong Kong	22-12-22	MT
OrbusNeich Medical Group Holdings Limited has completed an IPO in the amount of HKD 480.7704 million.	22-12-22	CI
OrbusNeich Raises HK$367 Million in Hong Kong IPO	22-12-21	MT

Chart OrbusNeich Medical Group Holdings Limited

Duration

Period

Chart OrbusNeich Medical Group Holdings Limited

More charts

Company Profile

OrbusNeich Medical Group Holdings Ltd is an investment holding company principally engaged in the development, production and sales of medical equipment and machineries. The Company is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The Company's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The Company mainly conducts its businesses in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Ratings for OrbusNeich Medical Group Holdings Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.545 CNY

Average target price

6.393 CNY

Spread / Average Target

+80.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED	-45.67%	405M
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7.19B
GLAUKOS CORPORATION	+25.15%	4.99B
AXONICS, INC.	+7.17%	3.4B
ENOVIS CORPORATION	-1.36%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2B

Medical Devices & Implants